KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Non Operating Income: 2013-2024

Historic Non Operating Income for Arbutus Biopharma (ABUS) over the last 12 years, with Dec 2024 value amounting to $6.4 million.

  • Arbutus Biopharma's Non Operating Income fell 46.78% to $917,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year decrease of 29.64%. This contributed to the annual value of $6.4 million for FY2024, which is 21.79% up from last year.
  • Latest data reveals that Arbutus Biopharma reported Non Operating Income of $6.4 million as of FY2024, which was up 21.79% from $5.3 million recorded in FY2023.
  • In the past 5 years, Arbutus Biopharma's Non Operating Income registered a high of $6.4 million during FY2024, and its lowest value of -$5.9 million during FY2020.
  • In the last 3 years, Arbutus Biopharma's Non Operating Income had a median value of $5.3 million in 2023 and averaged $4.0 million.
  • Data for Arbutus Biopharma's Non Operating Income shows a peak YoY spiked of 1,083.33% (in 2023) over the last 5 years.
  • Arbutus Biopharma's Non Operating Income (Yearly) stood at -$5.9 million in 2020, then soared by 54.12% to -$2.7 million in 2021, then soared by 116.29% to $444,000 in 2022, then spiked by 1,083.33% to $5.3 million in 2023, then rose by 21.79% to $6.4 million in 2024.